C. S. Lunde

发表

Membrane-protein stability in a phospholipid-based crystallization medium.

M. Facciotti, R. Glaeser, S. Rouhani, 2006, Journal of structural biology.

In vivo efficacy of the boron-pleuromutilin AN11251 against Wolbachia of the rodent filarial nematode Litomosoides sigmodontis

A. Hoerauf, S. Ward, Mark J. Taylor, 2020, PLoS neglected tropical diseases.

Boron-Pleuromutilins as Anti-Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis

Malina A. Bakowski, A. Hoerauf, Laura J. Myhill, 2019, Journal of medicinal chemistry.

Further Insights into the Mode of Action of the

C. S. Lunde, Yang Song, Bret M. Benton, 2012 .

Macrofilaricidal Benzimidazole–Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 2. Ketone Linked Analogs

J. McKerrow, S. Lustigman, J. Plattner, 2019, ACS infectious diseases.

Macrofilaricidal Benzimidazole–Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 1. Amide Linked Analogs

K. Jarnagin, A. Hoerauf, J. McKerrow, 2019, ACS infectious diseases.

Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis

J. Gut, C. Huston, J. Plattner, 2019, Nature Communications.

Microcrystal screening with a novel design for beamline-mountable crystallization wells

R. Glaeser, J. Remis, S. Rouhani, 2008 .

Effect of Polygodial on the Mitochondrial ATPase of Saccharomyces cerevisiae

I. Kubo, C. S. Lunde, C. Lunde, 2000, Antimicrobial Agents and Chemotherapy.

Saccharomyces cerevisiae ATPase of Effect of Polygodial on the Mitochondrial

I. Kubo, C. S. Lunde, 2000 .

Fluorescence Microscopy Demonstrates Enhanced Targeting of Telavancin to the Division Septum of Staphylococcus aureus

Stephanie R Hartouni, C. S. Lunde, C. Rexer, 2010, Antimicrobial Agents and Chemotherapy.

Studies on the mechanism of telavancin decreased susceptibility in a laboratory-derived mutant.

B. Wilkinson, C. S. Lunde, Yang Song, 2013, Microbial drug resistance.

Antimicrobial activity of the olive oil flavor compounds

I. Kubo, C. S. Lunde, A. Kubo, 1995 .

Telavancin Disrupts the Functional Integrity of the Bacterial Membrane through Targeted Interaction with the Cell Wall Precursor Lipid II

M. Mammen, J. Janc, Stephanie R Hartouni, 2009, Antimicrobial Agents and Chemotherapy.

In Vitro Antifungal Susceptibilities of Candida albicans and Other Fungal Pathogens to Polygodial, a Sesquiterpene Dialdehyde

I. Kubo, C. S. Lunde, S. H. Lee, 1999, Planta medica.

Indole and (E)-2-hexenal, phytochemical potentiators of polymyxins against Pseudomonas aeruginosa and Escherichia coli

I. Kubo, C. S. Lunde, A. Kubo, 1996, Antimicrobial agents and chemotherapy.

Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis

J. Gut, C. Huston, J. Plattner, 2019, Nature Communications.

In vitro activity of telavancin and occurrence of vancomycin heteroresistance in isolates from patients enrolled in phase 3 clinical trials of hospital-acquired pneumonia.

K. Krause, S. Barriere, C. S. Lunde, 2012, Diagnostic microbiology and infectious disease.

Further Insights into the Mode of Action of the Lipoglycopeptide Telavancin through Global Gene Expression Studies

B. Wilkinson, C. S. Lunde, Yang Song, 2012, Antimicrobial Agents and Chemotherapy.

Modes of antifungal action of (2E)-alkenals against Saccharomyces cerevisiae.

I. Kubo, Ken-Ichi Fujita, K. Nihei, 2003, Journal of agricultural and food chemistry.

Deprotonation of D96 in bacteriorhodopsin opens the proton uptake pathway.

M. Facciotti, Y. Duan, R. Glaeser, 2013, Structure.

O258 Telavancin inhibits peptidoglycan biosynthesis through preferential targeting of transglycosylation: evidence for a multivalent interaction between telavancin and lipid II

M. Mammen, J. Janc, E. Breukink, 2007 .